Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Current Accrued Expense: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company Current Accrued Expense?

Pharmedic Pharmaceutical Medicinal Joint Stock Company HSTC:PMC -2.50% Current Accrued Expense is ₫0.00 Mil as of . 20.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Current Accrued Expense for the quarter that ended in . 20 was ₫0.00 Mil.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Current Accrued Expense Related Terms

Pharmedic Pharmaceutical Medicinal Joint Stock Company Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Current Accrued Expense Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
Current Accrued Expense

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
Current Accrued Expense

Pharmedic Pharmaceutical Medicinal Joint Stock Company Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of ₫0.00 Mil mean?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a Current Accrued Expense of ₫0.00 Mil as of . 20. Current Accrued Expense records the total amount of accrued expenses. View historical data on Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company's Current Accrued Expense too high?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's current Current Accrued Expense is ₫0.00 Mil.
How does Pharmedic Pharmaceutical Medicinal Joint Stock Company's Current Accrued Expense compare to IMNPQ?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's Current Accrued Expense of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors. Pharmedic Pharmaceutical Medicinal Joint Stock Company's current Current Accrued Expense is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company stock overvalued right now?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a current Current Accrued Expense of ₫0.00 Mil. The current Current Accrued Expense is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC), the current Current Accrued Expense is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Business Description

Address 367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, cosmetics, medical supplies, and other products in the health sector. The company's products include Farzincol Bottle, Farzincol Syrup, Sibemag, Vitamin C 50, Vitamin PP 500, Vitamin PP 50, Nacofar, Cooldrop, Inhaler, Povidine 10% 90ml, Povidine 4% 500, Povidine 10% 8ml, and Povidine 4% 800.